Products 106518-63-2

CAS 106518-63-2 appears in our catalog under these names: Ganodermanontriol, Ganodermanontriol, 98%, 98%, Ganodermanontriol (Standard), Ganodermanontriol, 97.42%. Offered by: Chemat Brand, TargetMol, GLPBio, Biosynth, Chemat. Available pack sizes: on request, 1mg, 5mg, 2mg, 10mg, 25mg, Get quote, 5 mg.

Ganodermanontriol
Chemat Brand, TargetMol, GLPBio
  • size: on request, 1mg, 5mg, 2mg
  • Variants: 9
from 2010.55
View product
Ganodermanontriol, 98%, 98%
Chemat
  • size: 1mg, 5mg, 10mg
  • Variants: 3
from 654.80
View product
Ganodermanontriol (Standard)
MedChemExpress
  • size: Get quote
  • Variants: 1
View product
Ganodermanontriol, 97.42%
MedChemExpress
  • size: 5 mg, 10 mg, 1 mg, 50 mg
  • Variants: 6
from 695.86
View product
Structural formula: {0} (CAS {1})

Ganodermanontriol is a natural product found in Ganoderma lucidum. It has a role as a metabolite.

Source: ChEBI

Identity
Molecular formulaC30H48O4
Molecular weight472.7 g/mol
IUPAC name(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R,5S,6R)-5,6,7-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one
InChIKeyKASALCUNLBTNAA-LIPCCPSCSA-N
SMILESC[C@H](CC[C@@H]([C@@](C)(CO)O)O)[C@H]1CC[C@@]2([C@@]1(CC=C3C2=CC[C@@H]4[C@@]3(CCC(=O)C4(C)C)C)C)C

Computed by PubChem (NCBI)

Synonyms: Ganodermanontriol, (+)-Ganodermanontriol, 3-oxo-lanosta-7,9(11)-dien-24S,25R,26-triol, GNDT Triterpene, 26-Hydroxyganodermanondiol, (24S,25R)-24,25,26-Trihydroxylanosta-7,9(11)-dien-3-one, orb1709637, Lanosta-7,9(11)-dien-3-one, 24,25,26-trihydroxy-, (24S,25R)-, Lanosta-7\,9(11)-dien-3-one\, 24\,25\,26-trihydroxy-\, (24S\,25R)-
Isomers (same molecular formula)
(4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid C30H48O4
(4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-10-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid C30H48O4
(5R,9R,10R,13S,14S,17S)-17-[(1R)-1-[(2R,3R,4S)-3,4-dihydroxy-5,5-dimethyloxolan-2-yl]ethyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C30H48O4
(3S,4R,4aR,6aR,6bS,8R,8aS,14aR,14bS)-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicene-3,8-diol C30H48O4
(1R,3aS,5aR,5bR,7aR,8R,9S,11aR,11bR,13aR,13bR)-9-hydroxy-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid C30H48O4
(1S,2R,4aS,6aR,6aS,6bR,8aR,10S,11R,12aR,14bS)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid C30H48O4
(1S,2R,4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid C30H48O4